Old Web
English
Sign In
Acemap
>
authorDetail
>
Yuriko Monma
Yuriko Monma
Hitachi
Medicine
Immunology
Imatinib
Cmin
Internal medicine
3
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia
2011
International Journal of Hematology
Chikashi Yoshida
Takuya Komeno
Mitsuo Hori
Tomofumi Kimura
Masami Fujii
Yasushi Okoshi
Kazumi Suzukawa
Shigeru Chiba
Yuichi Hasegawa
Harumi Y. Mukai
Takayoshi Ito
Seiichi Shimizu
Masaharu Kamoshita
Daisuke Kudo
Atsushi Shinagawa
Norio Chikatsu
Yuriko Monma
Norimichi Watanabe
Hiroshi Kojima
Show All
Source
Cite
Save
Citations (22)
[Reported use of thalidomide in multiple myeloma: presentation of problems in the Thaled® outpatient department].
2011
Gan to kagaku ryoho. Cancer & chemotherapy
Aimono Y
Sato W
Otani E
Isa S
Sawahata T
Onozaki M
Saito Y
Ebata S
Aoyama Y
Hakozaki M
Suzuki M
Daisuke Kudo
Yuriko Monma
Norio Chikatsu
Atsushi Shinagawa
Show All
Source
Cite
Save
Citations (0)
Relevance of the Daily Dose of Imatinib Mesylate (IM) Rather Than Its Trough Plasma Concentration for Achieving Deep Molecular Response in Patients with Chronic Myeloid Leukemia.
2009
Blood
Chikashi Yoshida
Takuya Komeno
Mitsuo Hori
Tomofumi Kimura
Masami Fujii
Yasushi Okoshi
Kazumi Suzukawa
Shigeru Chiba
Yuichi Hasegawa
Harumi Y. Mukai
Takayoshi Ito
Seiichi Shimizu
Masaharu Kamoshita
Daisuke Kudo
Atsushi Shinagawa
Norio Chikatsu
Yuriko Monma
Norimichi Watanabe
Hiroshi Kojima
Show All
Source
Cite
Save
Citations (1)
1